$3.77
-0.15-3.83%
At Close: -
$3.75
-0.02-0.53%
After Hours: Sep 20, 7:35 PM EDT
15 minutes delayed
Sutro Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sutro Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.59 | $-0.79 | 25.3 % |
Mar 2024 | 2024-05-13 | $-0.95 | $-0.86 | -10.5 % |
Dec 2023 | 2024-03-25 | $0.52 | $-0.82 | 163.4 % |
Sep 2023 | 2023-11-13 | $-0.81 | $-0.74 | -9.46 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $25.71M | $21.02M | 22.3 % |
Mar 2024 | 2024-05-13 | $13.01M | $11.97M | 8.67 % |
Dec 2023 | 2024-03-25 | $113.72M | $11.81M | 862.9 % |
Sep 2023 | 2023-11-13 | $16.92M | $12.61M | 34.2 % |
Sutro Biopharma (STRO) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.59, which beat the estimate of $-0.79.
The Actual Revenue was $25.7M, which beat the estimate of $21M.
Browse earnings estimates, EPS, and revenue on all stocks.